(JP2013122062) PROBLEM TO BE SOLVED: To provide a liquid crystalline polyester resin composition capable of obtaining a molded article having high surface smoothness and pin press-fit strength and reduced in warping by solving at least a part of requirements for making compatible a surface smoothness, low warping and pin press-fit strength at high level to achieve miniaturization and refinement of the molded article.SOLUTION: The liquid crystalline resin composition contains at least 100 pts.wt. of a liquid crystalline polyester resin and 10-100 pts.wt. of a glass fiber. The weight-average fiber length of the glass fiber is 30-100 μm, and the glass fiber having the fiber length of 300-500 μm accounts for 0.1-5 wt.% of the whole glass fiber.

(JP2013122063) PROBLEM TO BE SOLVED: To provide a liquid crystalline polyester resin composition capable of obtaining a molded article having high snap fitting property and high self-tapping property.SOLUTION: The liquid crystalline polyester resin composition includes 100 pts.wt. of a liquid crystalline polyester resin comprising respective residues composed of hydroxybenzoic acid, 4,4'-dihydroxybiphenyl, hydroquinone, terephthalic acid and isophthalic acid, and 10-100 pts.wt. of a glass fiber. The weight-average fiber length (Mw) of the glass fiber is 200-500 μm, and the glass fiber having the fiber length of ≥1,500 μm accounts for 0.1-5.0 wt.% of the whole glass fiber.

(JP5751520) PROBLEM TO BE SOLVED: To provide a sputtering coil for a plasma chamber in a semiconductor fabrication system.SOLUTION: The coil is preferably made of the same type of material as a target so that atoms sputtered from the coil 104 combine with the atoms sputtered from the target 110 to form a layer of a desired type of material. The distribution of the material sputtered from the coil tends to be thicker at the edges of a substrate and thinner toward the center of the substrate. Such a distribution compensates for the distribution profile of the material sputtered from the target. As a consequence, the materials deposited from both the coil and the target can combine to form a layer of relatively uniform thickness from the center of the substrate to its edges.

(JP2013108089) PROBLEM TO BE SOLVED: To provide a silver luster pigment based on a platelet substrate multilayerly coated.SOLUTION: The silver luster pigment based on a multiply-coated platelet substrate contains: (A) a high-refractive film composed of TiOand having a thickness of 5 to 200 nm; (B) a colorless film having a refractive index of n≤1.8 and a thickness of 10 to 300 nm; (C) at least one layer of a high-refractive film composed of TiOand having a thickness of 5 to 200 nm; and optionally (D) at least one outside protective layer. There are also provided the uses for production of a coating, film, printing ink including security printing inks, plastic, ceramic material, and glass thereof, and pigment preparations and dry product forms in cosmetic blends.

(US8840783) A method of cleaning a membrane surface immersed in a liquid medium with a fluid flow, including the steps of providing a randomly generated intermittent or pulsed fluid flow along the membrane surface to dislodge fouling materials therefrom. A membrane module is also disclosed comprising a plurality of porous membranes (6) or a set of membrane modules (5) and a device (11) for providing a generally randomly generated, pulsed fluid flow such that, in use, said fluid flow moves past the surfaces of said membranes (6) to dislodge fouling materials therefrom.

(US8507641) Provided herein are methods for preparing vinylidene-terminated polyolefins. Further provided herein are sulfide-terminated polyolefins.

(US20130157850) The present invention relates to an improved nitrification inhibitor composition and its use in agricultural applications.

(US20130157062) Provision of a laminate excellent in weather resistance and gas barrier property and also excellent in adhesion between layers and its durability; and a process for producing such a laminate. A laminate which comprises a substrate sheet containing a fluororesin, and a gas barrier layer containing, as the main component, an inorganic compound composed of a metal and at least one member selected from the group consisting of oxygen, nitrogen and carbon, the gas barrier layer being directly laminated on at least one surface of the substrate sheet; wherein in a C1s spectrum of a surface of the substrate sheet on which the gas barrier layer is laminated, that is measured by X-ray photoelectron spectroscopy, the position of the highest peak present within a binding energy range of from 289 to 291 eV is present within a range of from 290.1 to 290.6 eV.

(JP5616470) PROBLEM TO BE SOLVED: To provide a polycarbonate resin material having improved high flowability, transparency and durability.SOLUTION: The resin composition comprises 100 pts.wt. of a polycarbonate-based resin (component A) comprising a polycarbonate-polyorganosiloxane copolymer (component A1) comprising polyorganosiloxane units having a number-average polymerization degree of 10 to 60 or comprising the component A1 and a polycarbonate except the component A1, wherein the content of the polyorganosiloxane units is 0.1 to 20 wt.% per 100 wt.% of the component A, and 0.1 to 20 pts.wt. of a flowability-improving agent (component B3), wherein the component B3 is polycaprolactone having a number-average mol. wt. of 1,000 to 70,000.

(JP2013082756) PROBLEM TO BE SOLVED: To provide a compound particularly useful as a protein kinase inhibitor for JAK family kinase to deal with the demand to develop a compound as a selective protein kinase inhibitor.SOLUTION: The invention relates to an inhibitor of protein kinase, particularly to the inhibitor of JAK2 and JAK3. The invention also provides a pharmaceutical composition comprising the compound, a process for preparing the compound, and a method of using the composition in the treatment of various disorders. The compound and the pharmaceutical composition thereof are useful for treatment or prevention of various disorders, including, but not limited to, an allergy, asthma, an autoimmune disease such as transplant rejection, rheumatoid arthritis, amyotrophic lateral sclerosis and multiple sclerosis, as well as solid and hematologic malignancies such as leukemia and lymphoma.